Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about ShieldCo
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
The provided sources do not mention "ShieldCo" but instead refer to "Shield Therapeutics plc." Here is a summary of the latest significant news for Shield Therapeutics plc: Shield Therapeutics remains on track to be cash flow positive by the end of 2025, with Q1 2025 net revenues of $6.4 million from Accrufer® prescriptions, despite early challenges[2][4].
There is no available information on "ShieldCo" from the provided sources, as they all refer to "Shield Therapeutics plc." If you need information on Shield Therapeutics plc, here is a summary: Shield Therapeutics remains on track to be cash flow positive by the end of 2025, with Q1 2025 net revenues of $6.4 million from Accrufer® prescriptions, despite early challenges[2].
There is no available information on "ShieldCo" from the provided sources, as they all refer to "Shield Therapeutics plc."
Open job positions at ShieldCo
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Branch Sales Professional
Field Manager - Pest Control

